Scholarlink

Purpose <p>Alzheimer’s Disease (AD) is a neurodegenerative condition which presents significant challenges in early diagnosis and clinical decision-making. This paper seeks to address key limitations in existing research—namely, a reliance on binary classification, a lack of model interpretability, and minimal consideration for clinical usability.</p> Methods <p>This paper presents <i>CogniNet</i>, a novel convolutional neural network (CNN) architecture specifically designed for the classification of Alzheimer’s progression using magnetic resonance imaging (MRI) data. <i>CogniNet</i> combines the architectural depth of VGGNet19 with the feature reuse and gradient efficiency of DenseNet201, mitigating vanishing gradients while promoting richer internal representations. Trained on axial slices from preprocessed T1-weighted MRI scans, the model performs four-way classification and uses gradient-weighted class activation mapping (Grad-CAM) to generate class-specific attention maps to visually highlight regions most influential to improve interpretability.</p> Results <p><i>CogniNet</i> was tested on 3,200 unseen axial MRI slices using standard performance metrics achieving 98% accuracy and 98% sensitivity. This paper compared <i>CogniNet’s</i> performance against several established CNN architectures and prior research and demonstrates improved performance.</p> Conclusion <p>These results highlight <i>CogniNet</i> as a high-performing and explainable deep learning model suitable for AI-assisted neuroimaging diagnostics. Beyond quantitative performance, the model provided interpretable outputs through Grad-CAM attention maps, allowing end users to visually audit which regions of the brain influenced predictions—an essential step toward clinical trust and adoption.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cogninet: an explainable deep learning model for multi-class MRI-based Alzheimer’s disease staging

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月17日

查看全文
  • Treeve White,
  • Sareh Rowlands

摘要

Purpose

Alzheimer’s Disease (AD) is a neurodegenerative condition which presents significant challenges in early diagnosis and clinical decision-making. This paper seeks to address key limitations in existing research—namely, a reliance on binary classification, a lack of model interpretability, and minimal consideration for clinical usability.

Methods

This paper presents CogniNet, a novel convolutional neural network (CNN) architecture specifically designed for the classification of Alzheimer’s progression using magnetic resonance imaging (MRI) data. CogniNet combines the architectural depth of VGGNet19 with the feature reuse and gradient efficiency of DenseNet201, mitigating vanishing gradients while promoting richer internal representations. Trained on axial slices from preprocessed T1-weighted MRI scans, the model performs four-way classification and uses gradient-weighted class activation mapping (Grad-CAM) to generate class-specific attention maps to visually highlight regions most influential to improve interpretability.

Results

CogniNet was tested on 3,200 unseen axial MRI slices using standard performance metrics achieving 98% accuracy and 98% sensitivity. This paper compared CogniNet’s performance against several established CNN architectures and prior research and demonstrates improved performance.

Conclusion

These results highlight CogniNet as a high-performing and explainable deep learning model suitable for AI-assisted neuroimaging diagnostics. Beyond quantitative performance, the model provided interpretable outputs through Grad-CAM attention maps, allowing end users to visually audit which regions of the brain influenced predictions—an essential step toward clinical trust and adoption.